According to IMARC Group’s latest report, titled “Defibrillators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global defibrillators market reached a value of US$ 4.7 Billion in 2021. Defibrillators are extensively used to deliver a therapeutic shock to the patient’s heart in severe cases of life-threatening conditions, such as pulseless ventricular tachycardia, cardiac arrhythmia, and ventricular fibrillation. The electric shock from the medical device depolarizes the heart muscles and restores its normal electric pulse. Manual/wearable defibrillators, automated external defibrillators (AED), transvenous or subcutaneous implantable cardioverter defibrillators, and implantable cardioverter defibrillators are most commonly available in the market.
Request for a PDF sample of this report: https://www.imarcgroup.com/defibrillators-market/requestsample
The rapidly rising prevalence of sudden cardiac arrest (SCA) and cardiovascular diseases across the globe is a key factor driving the defibrillators market growth. Additionally, the increasing geriatric population and shifting focus toward public access defibrillators (PAD) by the private and public organizations are contributing to the market growth. The initiatives undertaken by the government of various countries to increase awareness and promote training regarding defibrillators are acting as another growth-inducing factor. Other factors, such as the development of wearable cardioverter defibrillators (WCDs) and the rising government and private investments in the healthcare industry across the globe, are creating a positive outlook for the market. Looking forward, IMARC Group expects the defibrillators market to reach US$7.0 Billion by 2027, exhibiting a CAGR of 6.86% during 2022-2027.
Checkout Now: https://www.imarcgroup.com/checkout?id=2184&method=1
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Competitive Landscape with Key Players:
- Asahi Kasei Zoll Medical Corporation
- Boston Scientific Corporation
- Koninklijke Philips N.V.
- LivaNova PLC
- Medtronic Inc.
- Nihon Kohden Corporation
- Schiller AG
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- Stryker Corporation
Breakup by Product Type:
- Implantable Defibrillators
- Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
- Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
- Cardiac Resynchronization Therapy- Defibrillator (CRT-D)
- External Defibrillators
- Manual External Defibrillator
- Automated External Defibrillator (AEDs)
- Wearable Cardioverter Defibrillator (WCDs)
Breakup by End-User:
- Hospitals and Clinics
- Prehospital Care Settings
- Cardiac Centers
- Homecare Settings
Breakup by Region:
- North America
- United States
- Asia Pacific
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/defibrillators-market
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800